What Causes Hair Thinning After COVID Infection?

COVID-19 triggers noticeable hair thinning in a large share of people who catch the virus, with studies placing hair loss among the more common lingering symptoms of infection. The dominant pattern is a condition called telogen effluvium, in which a wave of hair follicles prematurely enters the shedding phase at once, producing diffuse thinning that typically shows up weeks after the illness itself has passed. The biology behind this involves more than one pathway, and the experience varies enough from person to person that a simple “it’ll grow back” doesn’t capture the full picture.

What Telogen Effluvium Actually Looks Like

Your hair normally cycles through growth, transition, and resting phases on a staggered schedule, so only a small percentage of strands are shedding at any given time. A major physiological shock, whether from high fever, surgery, severe illness, or emotional trauma, can push a much larger batch of follicles into the resting (telogen) phase simultaneously. Weeks later, when those resting hairs reach the end of their cycle, they all fall out in a short window. That’s telogen effluvium, and it’s the primary type of hair loss reported after COVID-19. In one cross-sectional study of 500 women who had been infected, about 61% reported hair problems afterward, with telogen effluvium accounting for the majority of cases.

1PubMed Central. Hair disorders associated with post-COVID-19 infection in females: a cross-sectional study

The hallmark of post-COVID telogen effluvium is diffuse shedding rather than bald patches. You notice more hair in the shower drain, on your pillow, and tangled in your brush. Because the loss is spread across the entire scalp, you don’t typically develop spots of bare skin the way you would with other forms of alopecia. A hair-pull test, where a clinician gently tugs a small section of hair, often comes back positive, with more strands than usual releasing easily.

2Coronaviruses. Clinical and trichoscopic features of post-COVID-19 telogen effluvium

Timing and Onset

Post-COVID hair shedding doesn’t happen while you’re sick with the virus, at least not usually. One study at a tertiary care hospital found the average onset was about 49 days after infection, with no meaningful difference between men and women.

3PubMed Central. A Cross-Sectional Study on Post-Coronavirus Disease (COVID-19) Hair Loss at a Tertiary Care Hospital

Other data puts the window at roughly two to three months after the acute illness, which aligns well with the known biology of telogen effluvium: follicles shocked into the resting phase during infection need those weeks in dormancy before they shed.

4PubMed Central. COVID-19 infection is a major cause of acute telogen effluvium

This delay is one reason the connection to COVID catches people off guard. By the time the thinning becomes visible, the infection itself is a distant memory. If you had a mild case in January and start losing hair in March, the link isn’t obvious unless you know to look for it. In one study of female patients, about 30% said their hair problems appeared only after COVID, while a larger group said pre-existing shedding got worse post-infection.

5PubMed Central. Hair disorders associated with post-COVID-19 infection in females: a cross-sectional study

How COVID Pushes Follicles Into Shedding

Several overlapping mechanisms are at work. The most widely discussed is the inflammatory cascade triggered by the virus. SARS-CoV-2 provokes a surge of pro-inflammatory cytokines and vasoactive substances that disrupt the normal metabolism of molecules called proteoglycans, which play an important role in keeping hair follicles in their active growth phase. When proteoglycan levels drop, follicles lose a biochemical signal they need to keep growing and instead shift prematurely toward shedding.

6PubMed Central. SARS-CoV-2 Infection-A Trigger Factor for Telogen Effluvium: Review of the Literature with a Case-Based Guidance for Clinical Evaluation

There may also be a more direct route. Some researchers have found ultrastructural evidence that the virus can infect hair follicle cells themselves during the growth phase, raising the possibility that SARS-CoV-2 doesn’t just cause collateral damage through systemic inflammation but targets follicular tissue directly.

7PubMed Central. Ultrastructural evidence for anagen hair follicle infection with SARS-CoV-2 in early-onset COVID-19 effluvium

Whether this direct infection is a major driver or a secondary contributor is still under investigation, but the finding adds complexity to a process that most earlier models treated as purely systemic.

The Stress Side of the Equation

COVID-era hair loss isn’t entirely explained by the virus’s biology. The pandemic itself was a prolonged psychological stressor, and stress alone is a well-established trigger for telogen effluvium. Quarantine, financial uncertainty, fear of illness, and social isolation all raised baseline stress levels for millions of people, and that psychological burden can independently push follicles into early shedding.

8Coronaviruses. COVID-19 Stress on Mental and Hair Health: A Marker for Diseases in the Post-Pandemic Era

The hormonal pathway behind stress-related hair loss involves the hypothalamic-pituitary-adrenal axis. When you’re under sustained stress, your body releases corticotropin-releasing factor, which binds to receptors on hair follicle cells and actively inhibits hair shaft growth while promoting the transition from growth to shedding. Elevated cortisol further degrades hyaluronan and proteoglycans in the skin, undermining follicle health. A neuropeptide called substance P adds to the damage by triggering localized inflammation around follicles and stimulating mast cell activity, which degrades the follicular environment.

9CosmoDerma. Hypothalamic-pituitary-adrenal axis, hair, and sebum: Stress-mediated dermatologic disasters of the pandemic era

In practice, separating “this person’s hair loss was caused by the virus” from “this person’s hair loss was caused by pandemic stress” is often impossible. For many people, both forces were acting at once, and the result was a stronger push toward shedding than either factor would have produced alone.

Nutrient Depletion After Infection

Fighting off a significant viral infection burns through nutritional reserves, and two nutrients that hair follicles depend on, iron (measured as ferritin) and vitamin D, often drop during and after COVID. One case-control study found that ferritin levels were significantly lower in COVID survivors who developed telogen effluvium compared to those who did not, though the average ferritin in the hair-loss group was still above the threshold doctors typically associate with iron-deficiency-related shedding. The researchers suggested that because ferritin is also an inflammatory marker that rises during acute infection, a post-infection dip might reflect the resolution of inflammation rather than true depletion, making it a less reliable biomarker in this context than it normally would be.

10PubMed Central. Post Covid telogen effluvium: the diagnostic value of serum ferritin biomarker and the preventive value of dietary supplements. a case control study

Separately, low vitamin D and low ferritin levels were both observed in women with more severe post-COVID hair loss, with the researchers noting that the body’s reserves of both nutrients get consumed during the immune response to the virus.

11Journal of Preventive, Diagnostic and Treatment Strategies in Medicine. The Effect of Ferritin, Vitamin D, and Some Hormonal and Biochemical Parameters on Patients with Female-pattern Hair Loss after COVID-19 Infection

None of this means that taking supplements will automatically prevent or reverse post-COVID thinning, but it does suggest that getting your blood levels checked after a significant bout of COVID is reasonable, especially if shedding begins weeks later.

Alopecia Areata, the Autoimmune Pattern

Not all post-COVID hair loss is telogen effluvium. A smaller but clinically distinct group develops alopecia areata, an autoimmune condition in which the immune system attacks hair follicles directly, producing circular bald patches rather than diffuse thinning. The mechanisms linking COVID to alopecia areata are different from those behind telogen effluvium. Researchers have proposed that molecular mimicry (where viral proteins resemble hair follicle proteins closely enough to confuse the immune system), cytokine shifts, and so-called bystander activation of immune cells may all play a role.

12JAMA Dermatology. Risk of Alopecia Areata After COVID-19

A literature review on the relationship between COVID and alopecia areata noted that the risk of autoimmune conditions in general goes up after infection, with the risk positively correlated with disease severity. Adults over 40 appeared to face a particularly elevated risk of alopecia areata post-COVID.

13PubMed Central. The correlation between corona virus disease 2019 and alopecia areata: a literature review

If you’re noticing distinct patches of smooth, bare scalp rather than overall thinning, that’s a different condition with different treatment paths and worth a dermatology visit sooner rather than later.

Hair Loss as a Long COVID Symptom

Hair thinning has earned a place on the growing list of long COVID symptoms. A systematic review and meta-analysis that pooled data from multiple studies of COVID survivors found a cumulative prevalence of about 25% for prolonged hair loss across over 2,000 patients.

14PubMed Central. Persistence of long COVID symptoms in COVID-19 survivors worldwide and its potential pathogenesis – A systematic review and meta-analysis

That number is strikingly high and puts hair loss alongside fatigue, brain fog, and shortness of breath as one of the more frequently reported complaints in the months following infection.

Interestingly, hair loss after COVID appears to be more common than after other comparable respiratory infections. A South Korean population study comparing post-infection complications between COVID and seasonal influenza found that COVID patients had a roughly 50% higher risk of hair loss than flu patients, even after standardizing for age.

15PubMed Central. Comparison of Complications after Coronavirus Disease and Seasonal Influenza, South Korea

That doesn’t mean the flu never causes hair shedding (it does), but it suggests something about SARS-CoV-2 in particular, whether its inflammatory profile, its potential to directly infect follicles, or the severity of illness it produces, is especially hard on hair.

Does COVID Vaccination Cause Hair Loss Too?

There have been reports of hair shedding after COVID vaccination as well, though the picture is murkier than with infection. A survey-based study among vaccinated individuals in Saudi Arabia found that roughly two-thirds reported post-vaccination hair fall, but when the researchers looked more closely, they attributed only about 28% of those cases to the vaccine specifically, with the rest chalked up to other causes or remaining unclear.

16PubMed Central. Telogen effluvium after COVID-19 vaccination among public in Saudi Arabia

Small case series have also documented alopecia areata flares after mRNA and viral vector vaccines, particularly in people who already had a history of the condition. In one report of five patients, all had been in remission from alopecia areata before vaccination, and the average time from the first dose to hair loss onset was about two weeks. The pattern tended to involve an initial flare after the first dose with stabilization on subsequent doses, though one patient experienced progressive worsening with each booster.

17PubMed Central. Alopecia Areata after COVID-19 Vaccines

Another case series tracked five patients who developed telogen effluvium or more severe alopecia after receiving a heterologous (mixed-type) vaccination scheme, with onset ranging from 3 to 17 days post-vaccination.

18PubMed Central. A Case Series and Literature Review of Telogen Effluvium and Alopecia Universalis after the Administration of a Heterologous COVID-19 Vaccine Scheme

These are small numbers, and case series can’t establish how common the problem is. The immune activation from a vaccine is far milder than from actual infection, so vaccine-related hair loss appears rarer and often milder. For someone with a history of autoimmune hair loss, though, it’s worth being aware of the possibility.

Treatment Approaches That Have Evidence Behind Them

The reassuring news about telogen effluvium in general is that it tends to be self-limiting. Once the triggering event passes and follicles begin cycling normally again, regrowth follows. For many people with post-COVID shedding, the hair starts to recover on its own within several months. That said, “wait it out” isn’t always a satisfying answer, especially when the thinning is distressing or when recovery seems slow.

Topical minoxidil is probably the most commonly recommended pharmacological option. It works by increasing blood flow to follicles and promoting the transition from the resting phase back to active growth. While it’s primarily studied in androgenetic alopecia (genetic-pattern hair loss), clinicians frequently prescribe it for chronic telogen effluvium as well. In the post-COVID context, the thinking is that starting minoxidil once the acute shedding phase begins to stabilize can help speed up regrowth rather than prevent the loss itself.

19Clinical, Cosmetic and Investigational Dermatology. Complementary Strategies to Promote Hair Regrowth in Post-COVID-19 Telogen Effluvium

On the nutritional side, oral supplements including vitamin D, zinc, and polyunsaturated fatty acids have shown promising results in some reports, and platelet-rich plasma therapy (where a concentrated sample of your own platelets is injected into the scalp) has been explored as a regenerative strategy with encouraging early outcomes.

20Journal of Education, Health and Sport. Hair loss following COVID-19 infection – the state of current knowledge and treatment approaches

Platelet-rich plasma and mesenchymal stem cell approaches are still in the early research phase for post-COVID hair loss specifically, but they represent a growing area of interest.

21PubMed Central. Hair Loss and Telogen Effluvium Related to COVID-19: The Potential Implication of Adipose-Derived Mesenchymal Stem Cells and Platelet-Rich Plasma as Regenerative Strategies

What’s likely not helpful is aggressively supplementing nutrients you’re not actually deficient in. Given the complicated relationship between ferritin and post-COVID inflammation discussed earlier, blindly taking high-dose iron supplements without a blood test can do more harm than good. A blood panel covering ferritin, vitamin D, thyroid function, and a basic metabolic panel gives a dermatologist a much clearer picture of whether nutritional support is warranted.

Who Is Most Affected

Women appear disproportionately affected by post-COVID hair loss across most studies, though men are not immune. In one hospital-based study of 198 patients admitted for COVID, 48 developed telogen effluvium, with women making up about 60% of the overall sample.

22PubMed Central. Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity

The gender skew may partly reflect the fact that women tend to notice and report diffuse thinning more readily than men, many of whom are already experiencing androgenetic alopecia and may attribute additional shedding to that. But biological differences in hormonal response and immune activation likely play a role as well.

Disease severity also matters. The relationship between how sick you were and how much hair you lose afterward seems to follow a gradient, with moderate-to-severe cases producing more dramatic shedding than mild ones. The literature review linking COVID to alopecia areata specifically noted a positive correlation between infection severity and the risk of autoimmune hair loss, with a particularly notable increase in risk among those over 40.

23PubMed Central. The correlation between corona virus disease 2019 and alopecia areata: a literature review

When Hair Loss Should Prompt a Clinic Visit

Mild diffuse shedding that starts a couple of months after a confirmed COVID infection and slowly improves on its own is, for most people, textbook telogen effluvium. But there are scenarios where getting evaluated matters. If the shedding continues beyond six months without improvement, if you notice distinct round patches of baldness rather than diffuse thinning, or if you have additional symptoms like scalp itching, scaling, or pain, these are signals that something other than straightforward telogen effluvium may be at play.

A dermatologist can use trichoscopy, a magnified examination of the scalp, to look for clues that distinguish conditions. In post-COVID telogen effluvium, trichoscopic features include follicles producing only a single hair instead of the usual cluster, reduced density, empty follicles, and short upright regrowing hairs, a sign that recovery has started.

24Coronaviruses. Clinical and trichoscopic features of post-COVID-19 telogen effluvium

Alopecia areata, by contrast, tends to show “exclamation-mark” hairs and a distinct pattern of black dots that signals a different kind of follicular damage. These patterns guide treatment decisions, and early intervention for autoimmune hair loss in particular can make a real difference in outcomes. If anything about your pattern of shedding feels unusual or isn’t improving after a few months, a clinical evaluation is the most efficient route to figuring out what’s going on and what, if anything, to do about it.